COVID-19 Impact on Global Insulin Needle-free Syringes Market Insights, Forecast to 2026
Insulin Needle-free Syringes market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Insulin Needle-free Syringes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Insulin Needle-free Syringes market is segmented into
The Insulin Needle-free Syringes market is analysed and market size information is provided by regions (countries).
The key regions covered in the Insulin Needle-free Syringes market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Insulin Needle-free Syringes Market Share Analysis
Insulin Needle-free Syringes market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Insulin Needle-free Syringes by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Insulin Needle-free Syringes business, the date to enter into the Insulin Needle-free Syringes market, Insulin Needle-free Syringes product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Insulin Needle-free Syringes market is segmented into
- Powder Injections
- Liquid Injections
- Hospital
- Clinic
- Other
The Insulin Needle-free Syringes market is analysed and market size information is provided by regions (countries).
The key regions covered in the Insulin Needle-free Syringes market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Insulin Needle-free Syringes Market Share Analysis
Insulin Needle-free Syringes market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Insulin Needle-free Syringes by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Insulin Needle-free Syringes business, the date to enter into the Insulin Needle-free Syringes market, Insulin Needle-free Syringes product introduction, recent developments, etc.
The major vendors covered:
- Zogenix
- Inovio
- Glide Pharma
- Akra Dermojet
- Crossject Medical Technology
- Injex Pharma
- Eternity Healthcare
- Antares Pharma
- Valeritas
- Medical International Technologies
- Penjet
- PharmaJet
- National Medical Products
1 STUDY COVERAGE
1.1 Insulin Needle-free Syringes Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Insulin Needle-free Syringes Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Insulin Needle-free Syringes Market Size Growth Rate by Type
1.4.2 Powder Injections
1.4.3 Liquid Injections
1.5 Market by Application
1.5.1 Global Insulin Needle-free Syringes Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Insulin Needle-free Syringes Industry Impact
1.6.1 How the Covid-19 is Affecting the Insulin Needle-free Syringes Industry
1.6.1.1 Insulin Needle-free Syringes Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Insulin Needle-free Syringes Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Insulin Needle-free Syringes Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Insulin Needle-free Syringes Market Size Estimates and Forecasts
2.1.1 Global Insulin Needle-free Syringes Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Insulin Needle-free Syringes Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Insulin Needle-free Syringes Production Estimates and Forecasts 2015-2026
2.2 Global Insulin Needle-free Syringes Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Insulin Needle-free Syringes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Insulin Needle-free Syringes Manufacturers Geographical Distribution
2.4 Key Trends for Insulin Needle-free Syringes Markets & Products
2.5 Primary Interviews with Key Insulin Needle-free Syringes Players (Opinion Leaders)
3 MARKET SIZE BY MANUFACTURERS
3.1 Global Top Insulin Needle-free Syringes Manufacturers by Production Capacity
3.1.1 Global Top Insulin Needle-free Syringes Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Insulin Needle-free Syringes Manufacturers by Production (2015-2020)
3.1.3 Global Top Insulin Needle-free Syringes Manufacturers Market Share by Production
3.2 Global Top Insulin Needle-free Syringes Manufacturers by Revenue
3.2.1 Global Top Insulin Needle-free Syringes Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Insulin Needle-free Syringes Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Insulin Needle-free Syringes Revenue in 2019
3.3 Global Insulin Needle-free Syringes Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 INSULIN NEEDLE-FREE SYRINGES PRODUCTION BY REGIONS
4.1 Global Insulin Needle-free Syringes Historic Market Facts & Figures by Regions
4.1.1 Global Top Insulin Needle-free Syringes Regions by Production (2015-2020)
4.1.2 Global Top Insulin Needle-free Syringes Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Insulin Needle-free Syringes Production (2015-2020)
4.2.2 North America Insulin Needle-free Syringes Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Insulin Needle-free Syringes Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Insulin Needle-free Syringes Production (2015-2020)
4.3.2 Europe Insulin Needle-free Syringes Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Insulin Needle-free Syringes Import & Export (2015-2020)
4.4 China
4.4.1 China Insulin Needle-free Syringes Production (2015-2020)
4.4.2 China Insulin Needle-free Syringes Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Insulin Needle-free Syringes Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Insulin Needle-free Syringes Production (2015-2020)
4.5.2 Japan Insulin Needle-free Syringes Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Insulin Needle-free Syringes Import & Export (2015-2020)
5 INSULIN NEEDLE-FREE SYRINGES CONSUMPTION BY REGION
5.1 Global Top Insulin Needle-free Syringes Regions by Consumption
5.1.1 Global Top Insulin Needle-free Syringes Regions by Consumption (2015-2020)
5.1.2 Global Top Insulin Needle-free Syringes Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Insulin Needle-free Syringes Consumption by Application
5.2.2 North America Insulin Needle-free Syringes Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Insulin Needle-free Syringes Consumption by Application
5.3.2 Europe Insulin Needle-free Syringes Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Insulin Needle-free Syringes Consumption by Application
5.4.2 Asia Pacific Insulin Needle-free Syringes Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Insulin Needle-free Syringes Consumption by Application
5.5.2 Central & South America Insulin Needle-free Syringes Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Insulin Needle-free Syringes Consumption by Application
5.6.2 Middle East and Africa Insulin Needle-free Syringes Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 MARKET SIZE BY TYPE (2015-2026)
6.1 Global Insulin Needle-free Syringes Market Size by Type (2015-2020)
6.1.1 Global Insulin Needle-free Syringes Production by Type (2015-2020)
6.1.2 Global Insulin Needle-free Syringes Revenue by Type (2015-2020)
6.1.3 Insulin Needle-free Syringes Price by Type (2015-2020)
6.2 Global Insulin Needle-free Syringes Market Forecast by Type (2021-2026)
6.2.1 Global Insulin Needle-free Syringes Production Forecast by Type (2021-2026)
6.2.2 Global Insulin Needle-free Syringes Revenue Forecast by Type (2021-2026)
6.2.3 Global Insulin Needle-free Syringes Price Forecast by Type (2021-2026)
6.3 Global Insulin Needle-free Syringes Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 MARKET SIZE BY APPLICATION (2015-2026)
7.2.1 Global Insulin Needle-free Syringes Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Insulin Needle-free Syringes Consumption Forecast by Application (2021-2026)
8 CORPORATE PROFILES
8.1 Zogenix
8.1.1 Zogenix Corporation Information
8.1.2 Zogenix Overview and Its Total Revenue
8.1.3 Zogenix Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Zogenix Product Description
8.1.5 Zogenix Recent Development
8.2 Inovio
8.2.1 Inovio Corporation Information
8.2.2 Inovio Overview and Its Total Revenue
8.2.3 Inovio Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Inovio Product Description
8.2.5 Inovio Recent Development
8.3 Glide Pharma
8.3.1 Glide Pharma Corporation Information
8.3.2 Glide Pharma Overview and Its Total Revenue
8.3.3 Glide Pharma Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Glide Pharma Product Description
8.3.5 Glide Pharma Recent Development
8.4 Akra Dermojet
8.4.1 Akra Dermojet Corporation Information
8.4.2 Akra Dermojet Overview and Its Total Revenue
8.4.3 Akra Dermojet Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Akra Dermojet Product Description
8.4.5 Akra Dermojet Recent Development
8.5 Crossject Medical Technology
8.5.1 Crossject Medical Technology Corporation Information
8.5.2 Crossject Medical Technology Overview and Its Total Revenue
8.5.3 Crossject Medical Technology Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Crossject Medical Technology Product Description
8.5.5 Crossject Medical Technology Recent Development
8.6 Injex Pharma
8.6.1 Injex Pharma Corporation Information
8.6.2 Injex Pharma Overview and Its Total Revenue
8.6.3 Injex Pharma Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Injex Pharma Product Description
8.6.5 Injex Pharma Recent Development
8.7 Eternity Healthcare
8.7.1 Eternity Healthcare Corporation Information
8.7.2 Eternity Healthcare Overview and Its Total Revenue
8.7.3 Eternity Healthcare Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Eternity Healthcare Product Description
8.7.5 Eternity Healthcare Recent Development
8.8 Antares Pharma
8.8.1 Antares Pharma Corporation Information
8.8.2 Antares Pharma Overview and Its Total Revenue
8.8.3 Antares Pharma Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 Antares Pharma Product Description
8.8.5 Antares Pharma Recent Development
8.9 Valeritas
8.9.1 Valeritas Corporation Information
8.9.2 Valeritas Overview and Its Total Revenue
8.9.3 Valeritas Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Valeritas Product Description
8.9.5 Valeritas Recent Development
8.10 Medical International Technologies
8.10.1 Medical International Technologies Corporation Information
8.10.2 Medical International Technologies Overview and Its Total Revenue
8.10.3 Medical International Technologies Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Medical International Technologies Product Description
8.10.5 Medical International Technologies Recent Development
8.11 Penjet
8.11.1 Penjet Corporation Information
8.11.2 Penjet Overview and Its Total Revenue
8.11.3 Penjet Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 Penjet Product Description
8.11.5 Penjet Recent Development
8.12 PharmaJet
8.12.1 PharmaJet Corporation Information
8.12.2 PharmaJet Overview and Its Total Revenue
8.12.3 PharmaJet Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.12.4 PharmaJet Product Description
8.12.5 PharmaJet Recent Development
8.13 National Medical Products
8.13.1 National Medical Products Corporation Information
8.13.2 National Medical Products Overview and Its Total Revenue
8.13.3 National Medical Products Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.13.4 National Medical Products Product Description
8.13.5 National Medical Products Recent Development
8.14 Activa Brand Products
8.14.1 Activa Brand Products Corporation Information
8.14.2 Activa Brand Products Overview and Its Total Revenue
8.14.3 Activa Brand Products Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.14.4 Activa Brand Products Product Description
8.14.5 Activa Brand Products Recent Development
9 PRODUCTION FORECASTS BY REGIONS
9.1 Global Top Insulin Needle-free Syringes Regions Forecast by Revenue (2021-2026)
9.2 Global Top Insulin Needle-free Syringes Regions Forecast by Production (2021-2026)
9.3 Key Insulin Needle-free Syringes Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 INSULIN NEEDLE-FREE SYRINGES CONSUMPTION FORECAST BY REGION
10.1 Global Insulin Needle-free Syringes Consumption Forecast by Region (2021-2026)
10.2 North America Insulin Needle-free Syringes Consumption Forecast by Region (2021-2026)
10.3 Europe Insulin Needle-free Syringes Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Insulin Needle-free Syringes Consumption Forecast by Region (2021-2026)
10.5 Latin America Insulin Needle-free Syringes Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Insulin Needle-free Syringes Consumption Forecast by Region (2021-2026)
11 VALUE CHAIN AND SALES CHANNELS ANALYSIS
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Insulin Needle-free Syringes Sales Channels
11.2.2 Insulin Needle-free Syringes Distributors
11.3 Insulin Needle-free Syringes Customers
12 MARKET OPPORTUNITIES & CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 KEY FINDING IN THE GLOBAL INSULIN NEEDLE-FREE SYRINGES STUDY
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
1.1 Insulin Needle-free Syringes Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Insulin Needle-free Syringes Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Insulin Needle-free Syringes Market Size Growth Rate by Type
1.4.2 Powder Injections
1.4.3 Liquid Injections
1.5 Market by Application
1.5.1 Global Insulin Needle-free Syringes Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Insulin Needle-free Syringes Industry Impact
1.6.1 How the Covid-19 is Affecting the Insulin Needle-free Syringes Industry
1.6.1.1 Insulin Needle-free Syringes Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Insulin Needle-free Syringes Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Insulin Needle-free Syringes Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Insulin Needle-free Syringes Market Size Estimates and Forecasts
2.1.1 Global Insulin Needle-free Syringes Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Insulin Needle-free Syringes Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Insulin Needle-free Syringes Production Estimates and Forecasts 2015-2026
2.2 Global Insulin Needle-free Syringes Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Insulin Needle-free Syringes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Insulin Needle-free Syringes Manufacturers Geographical Distribution
2.4 Key Trends for Insulin Needle-free Syringes Markets & Products
2.5 Primary Interviews with Key Insulin Needle-free Syringes Players (Opinion Leaders)
3 MARKET SIZE BY MANUFACTURERS
3.1 Global Top Insulin Needle-free Syringes Manufacturers by Production Capacity
3.1.1 Global Top Insulin Needle-free Syringes Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Insulin Needle-free Syringes Manufacturers by Production (2015-2020)
3.1.3 Global Top Insulin Needle-free Syringes Manufacturers Market Share by Production
3.2 Global Top Insulin Needle-free Syringes Manufacturers by Revenue
3.2.1 Global Top Insulin Needle-free Syringes Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Insulin Needle-free Syringes Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Insulin Needle-free Syringes Revenue in 2019
3.3 Global Insulin Needle-free Syringes Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 INSULIN NEEDLE-FREE SYRINGES PRODUCTION BY REGIONS
4.1 Global Insulin Needle-free Syringes Historic Market Facts & Figures by Regions
4.1.1 Global Top Insulin Needle-free Syringes Regions by Production (2015-2020)
4.1.2 Global Top Insulin Needle-free Syringes Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Insulin Needle-free Syringes Production (2015-2020)
4.2.2 North America Insulin Needle-free Syringes Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Insulin Needle-free Syringes Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Insulin Needle-free Syringes Production (2015-2020)
4.3.2 Europe Insulin Needle-free Syringes Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Insulin Needle-free Syringes Import & Export (2015-2020)
4.4 China
4.4.1 China Insulin Needle-free Syringes Production (2015-2020)
4.4.2 China Insulin Needle-free Syringes Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Insulin Needle-free Syringes Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Insulin Needle-free Syringes Production (2015-2020)
4.5.2 Japan Insulin Needle-free Syringes Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Insulin Needle-free Syringes Import & Export (2015-2020)
5 INSULIN NEEDLE-FREE SYRINGES CONSUMPTION BY REGION
5.1 Global Top Insulin Needle-free Syringes Regions by Consumption
5.1.1 Global Top Insulin Needle-free Syringes Regions by Consumption (2015-2020)
5.1.2 Global Top Insulin Needle-free Syringes Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Insulin Needle-free Syringes Consumption by Application
5.2.2 North America Insulin Needle-free Syringes Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Insulin Needle-free Syringes Consumption by Application
5.3.2 Europe Insulin Needle-free Syringes Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Insulin Needle-free Syringes Consumption by Application
5.4.2 Asia Pacific Insulin Needle-free Syringes Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Insulin Needle-free Syringes Consumption by Application
5.5.2 Central & South America Insulin Needle-free Syringes Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Insulin Needle-free Syringes Consumption by Application
5.6.2 Middle East and Africa Insulin Needle-free Syringes Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 MARKET SIZE BY TYPE (2015-2026)
6.1 Global Insulin Needle-free Syringes Market Size by Type (2015-2020)
6.1.1 Global Insulin Needle-free Syringes Production by Type (2015-2020)
6.1.2 Global Insulin Needle-free Syringes Revenue by Type (2015-2020)
6.1.3 Insulin Needle-free Syringes Price by Type (2015-2020)
6.2 Global Insulin Needle-free Syringes Market Forecast by Type (2021-2026)
6.2.1 Global Insulin Needle-free Syringes Production Forecast by Type (2021-2026)
6.2.2 Global Insulin Needle-free Syringes Revenue Forecast by Type (2021-2026)
6.2.3 Global Insulin Needle-free Syringes Price Forecast by Type (2021-2026)
6.3 Global Insulin Needle-free Syringes Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 MARKET SIZE BY APPLICATION (2015-2026)
7.2.1 Global Insulin Needle-free Syringes Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Insulin Needle-free Syringes Consumption Forecast by Application (2021-2026)
8 CORPORATE PROFILES
8.1 Zogenix
8.1.1 Zogenix Corporation Information
8.1.2 Zogenix Overview and Its Total Revenue
8.1.3 Zogenix Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Zogenix Product Description
8.1.5 Zogenix Recent Development
8.2 Inovio
8.2.1 Inovio Corporation Information
8.2.2 Inovio Overview and Its Total Revenue
8.2.3 Inovio Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Inovio Product Description
8.2.5 Inovio Recent Development
8.3 Glide Pharma
8.3.1 Glide Pharma Corporation Information
8.3.2 Glide Pharma Overview and Its Total Revenue
8.3.3 Glide Pharma Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Glide Pharma Product Description
8.3.5 Glide Pharma Recent Development
8.4 Akra Dermojet
8.4.1 Akra Dermojet Corporation Information
8.4.2 Akra Dermojet Overview and Its Total Revenue
8.4.3 Akra Dermojet Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Akra Dermojet Product Description
8.4.5 Akra Dermojet Recent Development
8.5 Crossject Medical Technology
8.5.1 Crossject Medical Technology Corporation Information
8.5.2 Crossject Medical Technology Overview and Its Total Revenue
8.5.3 Crossject Medical Technology Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Crossject Medical Technology Product Description
8.5.5 Crossject Medical Technology Recent Development
8.6 Injex Pharma
8.6.1 Injex Pharma Corporation Information
8.6.2 Injex Pharma Overview and Its Total Revenue
8.6.3 Injex Pharma Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Injex Pharma Product Description
8.6.5 Injex Pharma Recent Development
8.7 Eternity Healthcare
8.7.1 Eternity Healthcare Corporation Information
8.7.2 Eternity Healthcare Overview and Its Total Revenue
8.7.3 Eternity Healthcare Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Eternity Healthcare Product Description
8.7.5 Eternity Healthcare Recent Development
8.8 Antares Pharma
8.8.1 Antares Pharma Corporation Information
8.8.2 Antares Pharma Overview and Its Total Revenue
8.8.3 Antares Pharma Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 Antares Pharma Product Description
8.8.5 Antares Pharma Recent Development
8.9 Valeritas
8.9.1 Valeritas Corporation Information
8.9.2 Valeritas Overview and Its Total Revenue
8.9.3 Valeritas Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Valeritas Product Description
8.9.5 Valeritas Recent Development
8.10 Medical International Technologies
8.10.1 Medical International Technologies Corporation Information
8.10.2 Medical International Technologies Overview and Its Total Revenue
8.10.3 Medical International Technologies Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Medical International Technologies Product Description
8.10.5 Medical International Technologies Recent Development
8.11 Penjet
8.11.1 Penjet Corporation Information
8.11.2 Penjet Overview and Its Total Revenue
8.11.3 Penjet Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 Penjet Product Description
8.11.5 Penjet Recent Development
8.12 PharmaJet
8.12.1 PharmaJet Corporation Information
8.12.2 PharmaJet Overview and Its Total Revenue
8.12.3 PharmaJet Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.12.4 PharmaJet Product Description
8.12.5 PharmaJet Recent Development
8.13 National Medical Products
8.13.1 National Medical Products Corporation Information
8.13.2 National Medical Products Overview and Its Total Revenue
8.13.3 National Medical Products Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.13.4 National Medical Products Product Description
8.13.5 National Medical Products Recent Development
8.14 Activa Brand Products
8.14.1 Activa Brand Products Corporation Information
8.14.2 Activa Brand Products Overview and Its Total Revenue
8.14.3 Activa Brand Products Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.14.4 Activa Brand Products Product Description
8.14.5 Activa Brand Products Recent Development
9 PRODUCTION FORECASTS BY REGIONS
9.1 Global Top Insulin Needle-free Syringes Regions Forecast by Revenue (2021-2026)
9.2 Global Top Insulin Needle-free Syringes Regions Forecast by Production (2021-2026)
9.3 Key Insulin Needle-free Syringes Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 INSULIN NEEDLE-FREE SYRINGES CONSUMPTION FORECAST BY REGION
10.1 Global Insulin Needle-free Syringes Consumption Forecast by Region (2021-2026)
10.2 North America Insulin Needle-free Syringes Consumption Forecast by Region (2021-2026)
10.3 Europe Insulin Needle-free Syringes Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Insulin Needle-free Syringes Consumption Forecast by Region (2021-2026)
10.5 Latin America Insulin Needle-free Syringes Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Insulin Needle-free Syringes Consumption Forecast by Region (2021-2026)
11 VALUE CHAIN AND SALES CHANNELS ANALYSIS
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Insulin Needle-free Syringes Sales Channels
11.2.2 Insulin Needle-free Syringes Distributors
11.3 Insulin Needle-free Syringes Customers
12 MARKET OPPORTUNITIES & CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 KEY FINDING IN THE GLOBAL INSULIN NEEDLE-FREE SYRINGES STUDY
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
LIST OF TABLES
Table 1. Insulin Needle-free Syringes Key Market Segments in This Study
Table 2. Ranking of Global Top Insulin Needle-free Syringes Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Insulin Needle-free Syringes Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of Powder Injections
Table 5. Major Manufacturers of Liquid Injections
Table 6. COVID-19 Impact Global Market: (Four Insulin Needle-free Syringes Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Insulin Needle-free Syringes Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Insulin Needle-free Syringes Players to Combat Covid-19 Impact
Table 11. Global Insulin Needle-free Syringes Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Insulin Needle-free Syringes Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Insulin Needle-free Syringes by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin Needle-free Syringes as of 2019)
Table 15. Insulin Needle-free Syringes Manufacturing Base Distribution and Headquarters
Table 16. Manufacturers Insulin Needle-free Syringes Product Offered
Table 17. Date of Manufacturers Enter into Insulin Needle-free Syringes Market
Table 18. Key Trends for Insulin Needle-free Syringes Markets & Products
Table 19. Main Points Interviewed from Key Insulin Needle-free Syringes Players
Table 20. Global Insulin Needle-free Syringes Production Capacity by Manufacturers (2015-2020) (K Units)
Table 21. Global Insulin Needle-free Syringes Production Share by Manufacturers (2015-2020)
Table 22. Insulin Needle-free Syringes Revenue by Manufacturers (2015-2020) (Million US$)
Table 23. Insulin Needle-free Syringes Revenue Share by Manufacturers (2015-2020)
Table 24. Insulin Needle-free Syringes Price by Manufacturers 2015-2020 (USD/Unit)
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Insulin Needle-free Syringes Production by Regions (2015-2020) (K Units)
Table 27. Global Insulin Needle-free Syringes Production Market Share by Regions (2015-2020)
Table 28. Global Insulin Needle-free Syringes Revenue by Regions (2015-2020) (US$ Million)
Table 29. Global Insulin Needle-free Syringes Revenue Market Share by Regions (2015-2020)
Table 30. Key Insulin Needle-free Syringes Players in North America
Table 31. Import & Export of Insulin Needle-free Syringes in North America (K Units)
Table 32. Key Insulin Needle-free Syringes Players in Europe
Table 33. Import & Export of Insulin Needle-free Syringes in Europe (K Units)
Table 34. Key Insulin Needle-free Syringes Players in China
Table 35. Import & Export of Insulin Needle-free Syringes in China (K Units)
Table 36. Key Insulin Needle-free Syringes Players in Japan
Table 37. Import & Export of Insulin Needle-free Syringes in Japan (K Units)
Table 38. Global Insulin Needle-free Syringes Consumption by Regions (2015-2020) (K Units)
Table 39. Global Insulin Needle-free Syringes Consumption Market Share by Regions (2015-2020)
Table 40. North America Insulin Needle-free Syringes Consumption by Application (2015-2020) (K Units)
Table 41. North America Insulin Needle-free Syringes Consumption by Countries (2015-2020) (K Units)
Table 42. Europe Insulin Needle-free Syringes Consumption by Application (2015-2020) (K Units)
Table 43. Europe Insulin Needle-free Syringes Consumption by Countries (2015-2020) (K Units)
Table 44. Asia Pacific Insulin Needle-free Syringes Consumption by Application (2015-2020) (K Units)
Table 45. Asia Pacific Insulin Needle-free Syringes Consumption Market Share by Application (2015-2020) (K Units)
Table 46. Asia Pacific Insulin Needle-free Syringes Consumption by Regions (2015-2020) (K Units)
Table 47. Latin America Insulin Needle-free Syringes Consumption by Application (2015-2020) (K Units)
Table 48. Latin America Insulin Needle-free Syringes Consumption by Countries (2015-2020) (K Units)
Table 49. Middle East and Africa Insulin Needle-free Syringes Consumption by Application (2015-2020) (K Units)
Table 50. Middle East and Africa Insulin Needle-free Syringes Consumption by Countries (2015-2020) (K Units)
Table 51. Global Insulin Needle-free Syringes Production by Type (2015-2020) (K Units)
Table 52. Global Insulin Needle-free Syringes Production Share by Type (2015-2020)
Table 53. Global Insulin Needle-free Syringes Revenue by Type (2015-2020) (Million US$)
Table 54. Global Insulin Needle-free Syringes Revenue Share by Type (2015-2020)
Table 55. Insulin Needle-free Syringes Price by Type 2015-2020 (USD/Unit)
Table 56. Global Insulin Needle-free Syringes Consumption by Application (2015-2020) (K Units)
Table 57. Global Insulin Needle-free Syringes Consumption by Application (2015-2020) (K Units)
Table 58. Global Insulin Needle-free Syringes Consumption Share by Application (2015-2020)
Table 59. Zogenix Corporation Information
Table 60. Zogenix Description and Major Businesses
Table 61. Zogenix Insulin Needle-free Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 62. Zogenix Product
Table 63. Zogenix Recent Development
Table 64. Inovio Corporation Information
Table 65. Inovio Description and Major Businesses
Table 66. Inovio Insulin Needle-free Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 67. Inovio Product
Table 68. Inovio Recent Development
Table 69. Glide Pharma Corporation Information
Table 70. Glide Pharma Description and Major Businesses
Table 71. Glide Pharma Insulin Needle-free Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Glide Pharma Product
Table 73. Glide Pharma Recent Development
Table 74. Akra Dermojet Corporation Information
Table 75. Akra Dermojet Description and Major Businesses
Table 76. Akra Dermojet Insulin Needle-free Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Akra Dermojet Product
Table 78. Akra Dermojet Recent Development
Table 79. Crossject Medical Technology Corporation Information
Table 80. Crossject Medical Technology Description and Major Businesses
Table 81. Crossject Medical Technology Insulin Needle-free Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Crossject Medical Technology Product
Table 83. Crossject Medical Technology Recent Development
Table 84. Injex Pharma Corporation Information
Table 85. Injex Pharma Description and Major Businesses
Table 86. Injex Pharma Insulin Needle-free Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Injex Pharma Product
Table 88. Injex Pharma Recent Development
Table 89. Eternity Healthcare Corporation Information
Table 90. Eternity Healthcare Description and Major Businesses
Table 91. Eternity Healthcare Insulin Needle-free Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Eternity Healthcare Product
Table 93. Eternity Healthcare Recent Development
Table 94. Antares Pharma Corporation Information
Table 95. Antares Pharma Description and Major Businesses
Table 96. Antares Pharma Insulin Needle-free Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Antares Pharma Product
Table 98. Antares Pharma Recent Development
Table 99. Valeritas Corporation Information
Table 100. Valeritas Description and Major Businesses
Table 101. Valeritas Insulin Needle-free Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Valeritas Product
Table 103. Valeritas Recent Development
Table 104. Medical International Technologies Corporation Information
Table 105. Medical International Technologies Description and Major Businesses
Table 106. Medical International Technologies Insulin Needle-free Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Medical International Technologies Product
Table 108. Medical International Technologies Recent Development
Table 109. Penjet Corporation Information
Table 110. Penjet Description and Major Businesses
Table 111. Penjet Insulin Needle-free Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Penjet Product
Table 113. Penjet Recent Development
Table 114. PharmaJet Corporation Information
Table 115. PharmaJet Description and Major Businesses
Table 116. PharmaJet Insulin Needle-free Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. PharmaJet Product
Table 118. PharmaJet Recent Development
Table 119. National Medical Products Corporation Information
Table 120. National Medical Products Description and Major Businesses
Table 121. National Medical Products Insulin Needle-free Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. National Medical Products Product
Table 123. National Medical Products Recent Development
Table 124. Activa Brand Products Corporation Information
Table 125. Activa Brand Products Description and Major Businesses
Table 126. Activa Brand Products Insulin Needle-free Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Activa Brand Products Product
Table 128. Activa Brand Products Recent Development
Table 129. Global Insulin Needle-free Syringes Revenue Forecast by Region (2021-2026) (Million US$)
Table 130. Global Insulin Needle-free Syringes Production Forecast by Regions (2021-2026) (K Units)
Table 131. Global Insulin Needle-free Syringes Production Forecast by Type (2021-2026) (K Units)
Table 132. Global Insulin Needle-free Syringes Revenue Forecast by Type (2021-2026) (Million US$)
Table 133. North America Insulin Needle-free Syringes Consumption Forecast by Regions (2021-2026) (K Units)
Table 134. Europe Insulin Needle-free Syringes Consumption Forecast by Regions (2021-2026) (K Units)
Table 135. Asia Pacific Insulin Needle-free Syringes Consumption Forecast by Regions (2021-2026) (K Units)
Table 136. Latin America Insulin Needle-free Syringes Consumption Forecast by Regions (2021-2026) (K Units)
Table 137. Middle East and Africa Insulin Needle-free Syringes Consumption Forecast by Regions (2021-2026) (K Units)
Table 138. Insulin Needle-free Syringes Distributors List
Table 139. Insulin Needle-free Syringes Customers List
Table 140. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 141. Key Challenges
Table 142. Market Risks
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 1. Insulin Needle-free Syringes Key Market Segments in This Study
Table 2. Ranking of Global Top Insulin Needle-free Syringes Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Insulin Needle-free Syringes Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of Powder Injections
Table 5. Major Manufacturers of Liquid Injections
Table 6. COVID-19 Impact Global Market: (Four Insulin Needle-free Syringes Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Insulin Needle-free Syringes Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Insulin Needle-free Syringes Players to Combat Covid-19 Impact
Table 11. Global Insulin Needle-free Syringes Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Insulin Needle-free Syringes Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Insulin Needle-free Syringes by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin Needle-free Syringes as of 2019)
Table 15. Insulin Needle-free Syringes Manufacturing Base Distribution and Headquarters
Table 16. Manufacturers Insulin Needle-free Syringes Product Offered
Table 17. Date of Manufacturers Enter into Insulin Needle-free Syringes Market
Table 18. Key Trends for Insulin Needle-free Syringes Markets & Products
Table 19. Main Points Interviewed from Key Insulin Needle-free Syringes Players
Table 20. Global Insulin Needle-free Syringes Production Capacity by Manufacturers (2015-2020) (K Units)
Table 21. Global Insulin Needle-free Syringes Production Share by Manufacturers (2015-2020)
Table 22. Insulin Needle-free Syringes Revenue by Manufacturers (2015-2020) (Million US$)
Table 23. Insulin Needle-free Syringes Revenue Share by Manufacturers (2015-2020)
Table 24. Insulin Needle-free Syringes Price by Manufacturers 2015-2020 (USD/Unit)
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Insulin Needle-free Syringes Production by Regions (2015-2020) (K Units)
Table 27. Global Insulin Needle-free Syringes Production Market Share by Regions (2015-2020)
Table 28. Global Insulin Needle-free Syringes Revenue by Regions (2015-2020) (US$ Million)
Table 29. Global Insulin Needle-free Syringes Revenue Market Share by Regions (2015-2020)
Table 30. Key Insulin Needle-free Syringes Players in North America
Table 31. Import & Export of Insulin Needle-free Syringes in North America (K Units)
Table 32. Key Insulin Needle-free Syringes Players in Europe
Table 33. Import & Export of Insulin Needle-free Syringes in Europe (K Units)
Table 34. Key Insulin Needle-free Syringes Players in China
Table 35. Import & Export of Insulin Needle-free Syringes in China (K Units)
Table 36. Key Insulin Needle-free Syringes Players in Japan
Table 37. Import & Export of Insulin Needle-free Syringes in Japan (K Units)
Table 38. Global Insulin Needle-free Syringes Consumption by Regions (2015-2020) (K Units)
Table 39. Global Insulin Needle-free Syringes Consumption Market Share by Regions (2015-2020)
Table 40. North America Insulin Needle-free Syringes Consumption by Application (2015-2020) (K Units)
Table 41. North America Insulin Needle-free Syringes Consumption by Countries (2015-2020) (K Units)
Table 42. Europe Insulin Needle-free Syringes Consumption by Application (2015-2020) (K Units)
Table 43. Europe Insulin Needle-free Syringes Consumption by Countries (2015-2020) (K Units)
Table 44. Asia Pacific Insulin Needle-free Syringes Consumption by Application (2015-2020) (K Units)
Table 45. Asia Pacific Insulin Needle-free Syringes Consumption Market Share by Application (2015-2020) (K Units)
Table 46. Asia Pacific Insulin Needle-free Syringes Consumption by Regions (2015-2020) (K Units)
Table 47. Latin America Insulin Needle-free Syringes Consumption by Application (2015-2020) (K Units)
Table 48. Latin America Insulin Needle-free Syringes Consumption by Countries (2015-2020) (K Units)
Table 49. Middle East and Africa Insulin Needle-free Syringes Consumption by Application (2015-2020) (K Units)
Table 50. Middle East and Africa Insulin Needle-free Syringes Consumption by Countries (2015-2020) (K Units)
Table 51. Global Insulin Needle-free Syringes Production by Type (2015-2020) (K Units)
Table 52. Global Insulin Needle-free Syringes Production Share by Type (2015-2020)
Table 53. Global Insulin Needle-free Syringes Revenue by Type (2015-2020) (Million US$)
Table 54. Global Insulin Needle-free Syringes Revenue Share by Type (2015-2020)
Table 55. Insulin Needle-free Syringes Price by Type 2015-2020 (USD/Unit)
Table 56. Global Insulin Needle-free Syringes Consumption by Application (2015-2020) (K Units)
Table 57. Global Insulin Needle-free Syringes Consumption by Application (2015-2020) (K Units)
Table 58. Global Insulin Needle-free Syringes Consumption Share by Application (2015-2020)
Table 59. Zogenix Corporation Information
Table 60. Zogenix Description and Major Businesses
Table 61. Zogenix Insulin Needle-free Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 62. Zogenix Product
Table 63. Zogenix Recent Development
Table 64. Inovio Corporation Information
Table 65. Inovio Description and Major Businesses
Table 66. Inovio Insulin Needle-free Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 67. Inovio Product
Table 68. Inovio Recent Development
Table 69. Glide Pharma Corporation Information
Table 70. Glide Pharma Description and Major Businesses
Table 71. Glide Pharma Insulin Needle-free Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Glide Pharma Product
Table 73. Glide Pharma Recent Development
Table 74. Akra Dermojet Corporation Information
Table 75. Akra Dermojet Description and Major Businesses
Table 76. Akra Dermojet Insulin Needle-free Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Akra Dermojet Product
Table 78. Akra Dermojet Recent Development
Table 79. Crossject Medical Technology Corporation Information
Table 80. Crossject Medical Technology Description and Major Businesses
Table 81. Crossject Medical Technology Insulin Needle-free Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Crossject Medical Technology Product
Table 83. Crossject Medical Technology Recent Development
Table 84. Injex Pharma Corporation Information
Table 85. Injex Pharma Description and Major Businesses
Table 86. Injex Pharma Insulin Needle-free Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Injex Pharma Product
Table 88. Injex Pharma Recent Development
Table 89. Eternity Healthcare Corporation Information
Table 90. Eternity Healthcare Description and Major Businesses
Table 91. Eternity Healthcare Insulin Needle-free Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Eternity Healthcare Product
Table 93. Eternity Healthcare Recent Development
Table 94. Antares Pharma Corporation Information
Table 95. Antares Pharma Description and Major Businesses
Table 96. Antares Pharma Insulin Needle-free Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Antares Pharma Product
Table 98. Antares Pharma Recent Development
Table 99. Valeritas Corporation Information
Table 100. Valeritas Description and Major Businesses
Table 101. Valeritas Insulin Needle-free Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Valeritas Product
Table 103. Valeritas Recent Development
Table 104. Medical International Technologies Corporation Information
Table 105. Medical International Technologies Description and Major Businesses
Table 106. Medical International Technologies Insulin Needle-free Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Medical International Technologies Product
Table 108. Medical International Technologies Recent Development
Table 109. Penjet Corporation Information
Table 110. Penjet Description and Major Businesses
Table 111. Penjet Insulin Needle-free Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Penjet Product
Table 113. Penjet Recent Development
Table 114. PharmaJet Corporation Information
Table 115. PharmaJet Description and Major Businesses
Table 116. PharmaJet Insulin Needle-free Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. PharmaJet Product
Table 118. PharmaJet Recent Development
Table 119. National Medical Products Corporation Information
Table 120. National Medical Products Description and Major Businesses
Table 121. National Medical Products Insulin Needle-free Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. National Medical Products Product
Table 123. National Medical Products Recent Development
Table 124. Activa Brand Products Corporation Information
Table 125. Activa Brand Products Description and Major Businesses
Table 126. Activa Brand Products Insulin Needle-free Syringes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Activa Brand Products Product
Table 128. Activa Brand Products Recent Development
Table 129. Global Insulin Needle-free Syringes Revenue Forecast by Region (2021-2026) (Million US$)
Table 130. Global Insulin Needle-free Syringes Production Forecast by Regions (2021-2026) (K Units)
Table 131. Global Insulin Needle-free Syringes Production Forecast by Type (2021-2026) (K Units)
Table 132. Global Insulin Needle-free Syringes Revenue Forecast by Type (2021-2026) (Million US$)
Table 133. North America Insulin Needle-free Syringes Consumption Forecast by Regions (2021-2026) (K Units)
Table 134. Europe Insulin Needle-free Syringes Consumption Forecast by Regions (2021-2026) (K Units)
Table 135. Asia Pacific Insulin Needle-free Syringes Consumption Forecast by Regions (2021-2026) (K Units)
Table 136. Latin America Insulin Needle-free Syringes Consumption Forecast by Regions (2021-2026) (K Units)
Table 137. Middle East and Africa Insulin Needle-free Syringes Consumption Forecast by Regions (2021-2026) (K Units)
Table 138. Insulin Needle-free Syringes Distributors List
Table 139. Insulin Needle-free Syringes Customers List
Table 140. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 141. Key Challenges
Table 142. Market Risks
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Insulin Needle-free Syringes Product Picture
Figure 2. Global Insulin Needle-free Syringes Production Market Share by Type in 2020 & 2026
Figure 3. Powder Injections Product Picture
Figure 4. Liquid Injections Product Picture
Figure 5. Global Insulin Needle-free Syringes Consumption Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Other
Figure 9. Insulin Needle-free Syringes Report Years Considered
Figure 10. Global Insulin Needle-free Syringes Revenue 2015-2026 (Million US$)
Figure 11. Global Insulin Needle-free Syringes Production Capacity 2015-2026 (K Units)
Figure 12. Global Insulin Needle-free Syringes Production 2015-2026 (K Units)
Figure 13. Global Insulin Needle-free Syringes Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 14. Insulin Needle-free Syringes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 15. Global Insulin Needle-free Syringes Production Share by Manufacturers in 2015
Figure 16. The Top 10 and Top 5 Players Market Share by Insulin Needle-free Syringes Revenue in 2019
Figure 17. Global Insulin Needle-free Syringes Production Market Share by Region (2015-2020)
Figure 18. Insulin Needle-free Syringes Production Growth Rate in North America (2015-2020) (K Units)
Figure 19. Insulin Needle-free Syringes Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 20. Insulin Needle-free Syringes Production Growth Rate in Europe (2015-2020) (K Units)
Figure 21. Insulin Needle-free Syringes Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 22. Insulin Needle-free Syringes Production Growth Rate in China (2015-2020) (K Units)
Figure 23. Insulin Needle-free Syringes Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 24. Insulin Needle-free Syringes Production Growth Rate in Japan (2015-2020) (K Units)
Figure 25. Insulin Needle-free Syringes Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 26. Global Insulin Needle-free Syringes Consumption Market Share by Regions 2015-2020
Figure 27. North America Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 28. North America Insulin Needle-free Syringes Consumption Market Share by Application in 2019
Figure 29. North America Insulin Needle-free Syringes Consumption Market Share by Countries in 2019
Figure 30. U.S. Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 31. Canada Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 32. Europe Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 33. Europe Insulin Needle-free Syringes Consumption Market Share by Application in 2019
Figure 34. Europe Insulin Needle-free Syringes Consumption Market Share by Countries in 2019
Figure 35. Germany Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 36. France Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 37. U.K. Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 38. Italy Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 39. Russia Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 40. Asia Pacific Insulin Needle-free Syringes Consumption and Growth Rate (K Units)
Figure 41. Asia Pacific Insulin Needle-free Syringes Consumption Market Share by Application in 2019
Figure 42. Asia Pacific Insulin Needle-free Syringes Consumption Market Share by Regions in 2019
Figure 43. China Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 44. Japan Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 45. South Korea Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 46. India Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 47. Australia Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 48. Taiwan Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 49. Indonesia Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. Thailand Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. Malaysia Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. Philippines Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Vietnam Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 54. Latin America Insulin Needle-free Syringes Consumption and Growth Rate (K Units)
Figure 55. Latin America Insulin Needle-free Syringes Consumption Market Share by Application in 2019
Figure 56. Latin America Insulin Needle-free Syringes Consumption Market Share by Countries in 2019
Figure 57. Mexico Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 58. Brazil Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 59. Argentina Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 60. Middle East and Africa Insulin Needle-free Syringes Consumption and Growth Rate (K Units)
Figure 61. Middle East and Africa Insulin Needle-free Syringes Consumption Market Share by Application in 2019
Figure 62. Middle East and Africa Insulin Needle-free Syringes Consumption Market Share by Countries in 2019
Figure 63. Turkey Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 64. Saudi Arabia Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 65. U.A.E Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 66. Global Insulin Needle-free Syringes Production Market Share by Type (2015-2020)
Figure 67. Global Insulin Needle-free Syringes Production Market Share by Type in 2019
Figure 68. Global Insulin Needle-free Syringes Revenue Market Share by Type (2015-2020)
Figure 69. Global Insulin Needle-free Syringes Revenue Market Share by Type in 2019
Figure 70. Global Insulin Needle-free Syringes Production Market Share Forecast by Type (2021-2026)
Figure 71. Global Insulin Needle-free Syringes Revenue Market Share Forecast by Type (2021-2026)
Figure 72. Global Insulin Needle-free Syringes Market Share by Price Range (2015-2020)
Figure 73. Global Insulin Needle-free Syringes Consumption Market Share by Application (2015-2020)
Figure 74. Global Insulin Needle-free Syringes Value (Consumption) Market Share by Application (2015-2020)
Figure 75. Global Insulin Needle-free Syringes Consumption Market Share Forecast by Application (2021-2026)
Figure 76. Zogenix Total Revenue (US$ Million): 2019 Compared with 2018
Figure 77. Inovio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 78. Glide Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 79. Akra Dermojet Total Revenue (US$ Million): 2019 Compared with 2018
Figure 80. Crossject Medical Technology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 81. Injex Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. Eternity Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. Antares Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. Valeritas Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. Medical International Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. Penjet Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. PharmaJet Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. National Medical Products Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Activa Brand Products Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Global Insulin Needle-free Syringes Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 91. Global Insulin Needle-free Syringes Revenue Market Share Forecast by Regions ((2021-2026))
Figure 92. Global Insulin Needle-free Syringes Production Forecast by Regions (2021-2026) (K Units)
Figure 93. North America Insulin Needle-free Syringes Production Forecast (2021-2026) (K Units)
Figure 94. North America Insulin Needle-free Syringes Revenue Forecast (2021-2026) (US$ Million)
Figure 95. Europe Insulin Needle-free Syringes Production Forecast (2021-2026) (K Units)
Figure 96. Europe Insulin Needle-free Syringes Revenue Forecast (2021-2026) (US$ Million)
Figure 97. China Insulin Needle-free Syringes Production Forecast (2021-2026) (K Units)
Figure 98. China Insulin Needle-free Syringes Revenue Forecast (2021-2026) (US$ Million)
Figure 99. Japan Insulin Needle-free Syringes Production Forecast (2021-2026) (K Units)
Figure 100. Japan Insulin Needle-free Syringes Revenue Forecast (2021-2026) (US$ Million)
Figure 101. Global Insulin Needle-free Syringes Consumption Market Share Forecast by Region (2021-2026)
Figure 102. Insulin Needle-free Syringes Value Chain
Figure 103. Channels of Distribution
Figure 104. Distributors Profiles
Figure 105. Porter's Five Forces Analysis
Figure 106. Bottom-up and Top-down Approaches for This Report
Figure 107. Data Triangulation
Figure 108. Key Executives Interviewed
Figure 1. Insulin Needle-free Syringes Product Picture
Figure 2. Global Insulin Needle-free Syringes Production Market Share by Type in 2020 & 2026
Figure 3. Powder Injections Product Picture
Figure 4. Liquid Injections Product Picture
Figure 5. Global Insulin Needle-free Syringes Consumption Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Other
Figure 9. Insulin Needle-free Syringes Report Years Considered
Figure 10. Global Insulin Needle-free Syringes Revenue 2015-2026 (Million US$)
Figure 11. Global Insulin Needle-free Syringes Production Capacity 2015-2026 (K Units)
Figure 12. Global Insulin Needle-free Syringes Production 2015-2026 (K Units)
Figure 13. Global Insulin Needle-free Syringes Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 14. Insulin Needle-free Syringes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 15. Global Insulin Needle-free Syringes Production Share by Manufacturers in 2015
Figure 16. The Top 10 and Top 5 Players Market Share by Insulin Needle-free Syringes Revenue in 2019
Figure 17. Global Insulin Needle-free Syringes Production Market Share by Region (2015-2020)
Figure 18. Insulin Needle-free Syringes Production Growth Rate in North America (2015-2020) (K Units)
Figure 19. Insulin Needle-free Syringes Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 20. Insulin Needle-free Syringes Production Growth Rate in Europe (2015-2020) (K Units)
Figure 21. Insulin Needle-free Syringes Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 22. Insulin Needle-free Syringes Production Growth Rate in China (2015-2020) (K Units)
Figure 23. Insulin Needle-free Syringes Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 24. Insulin Needle-free Syringes Production Growth Rate in Japan (2015-2020) (K Units)
Figure 25. Insulin Needle-free Syringes Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 26. Global Insulin Needle-free Syringes Consumption Market Share by Regions 2015-2020
Figure 27. North America Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 28. North America Insulin Needle-free Syringes Consumption Market Share by Application in 2019
Figure 29. North America Insulin Needle-free Syringes Consumption Market Share by Countries in 2019
Figure 30. U.S. Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 31. Canada Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 32. Europe Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 33. Europe Insulin Needle-free Syringes Consumption Market Share by Application in 2019
Figure 34. Europe Insulin Needle-free Syringes Consumption Market Share by Countries in 2019
Figure 35. Germany Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 36. France Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 37. U.K. Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 38. Italy Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 39. Russia Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 40. Asia Pacific Insulin Needle-free Syringes Consumption and Growth Rate (K Units)
Figure 41. Asia Pacific Insulin Needle-free Syringes Consumption Market Share by Application in 2019
Figure 42. Asia Pacific Insulin Needle-free Syringes Consumption Market Share by Regions in 2019
Figure 43. China Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 44. Japan Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 45. South Korea Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 46. India Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 47. Australia Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 48. Taiwan Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 49. Indonesia Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. Thailand Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. Malaysia Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. Philippines Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Vietnam Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 54. Latin America Insulin Needle-free Syringes Consumption and Growth Rate (K Units)
Figure 55. Latin America Insulin Needle-free Syringes Consumption Market Share by Application in 2019
Figure 56. Latin America Insulin Needle-free Syringes Consumption Market Share by Countries in 2019
Figure 57. Mexico Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 58. Brazil Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 59. Argentina Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 60. Middle East and Africa Insulin Needle-free Syringes Consumption and Growth Rate (K Units)
Figure 61. Middle East and Africa Insulin Needle-free Syringes Consumption Market Share by Application in 2019
Figure 62. Middle East and Africa Insulin Needle-free Syringes Consumption Market Share by Countries in 2019
Figure 63. Turkey Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 64. Saudi Arabia Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 65. U.A.E Insulin Needle-free Syringes Consumption and Growth Rate (2015-2020) (K Units)
Figure 66. Global Insulin Needle-free Syringes Production Market Share by Type (2015-2020)
Figure 67. Global Insulin Needle-free Syringes Production Market Share by Type in 2019
Figure 68. Global Insulin Needle-free Syringes Revenue Market Share by Type (2015-2020)
Figure 69. Global Insulin Needle-free Syringes Revenue Market Share by Type in 2019
Figure 70. Global Insulin Needle-free Syringes Production Market Share Forecast by Type (2021-2026)
Figure 71. Global Insulin Needle-free Syringes Revenue Market Share Forecast by Type (2021-2026)
Figure 72. Global Insulin Needle-free Syringes Market Share by Price Range (2015-2020)
Figure 73. Global Insulin Needle-free Syringes Consumption Market Share by Application (2015-2020)
Figure 74. Global Insulin Needle-free Syringes Value (Consumption) Market Share by Application (2015-2020)
Figure 75. Global Insulin Needle-free Syringes Consumption Market Share Forecast by Application (2021-2026)
Figure 76. Zogenix Total Revenue (US$ Million): 2019 Compared with 2018
Figure 77. Inovio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 78. Glide Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 79. Akra Dermojet Total Revenue (US$ Million): 2019 Compared with 2018
Figure 80. Crossject Medical Technology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 81. Injex Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. Eternity Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. Antares Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. Valeritas Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. Medical International Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. Penjet Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. PharmaJet Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. National Medical Products Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Activa Brand Products Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Global Insulin Needle-free Syringes Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 91. Global Insulin Needle-free Syringes Revenue Market Share Forecast by Regions ((2021-2026))
Figure 92. Global Insulin Needle-free Syringes Production Forecast by Regions (2021-2026) (K Units)
Figure 93. North America Insulin Needle-free Syringes Production Forecast (2021-2026) (K Units)
Figure 94. North America Insulin Needle-free Syringes Revenue Forecast (2021-2026) (US$ Million)
Figure 95. Europe Insulin Needle-free Syringes Production Forecast (2021-2026) (K Units)
Figure 96. Europe Insulin Needle-free Syringes Revenue Forecast (2021-2026) (US$ Million)
Figure 97. China Insulin Needle-free Syringes Production Forecast (2021-2026) (K Units)
Figure 98. China Insulin Needle-free Syringes Revenue Forecast (2021-2026) (US$ Million)
Figure 99. Japan Insulin Needle-free Syringes Production Forecast (2021-2026) (K Units)
Figure 100. Japan Insulin Needle-free Syringes Revenue Forecast (2021-2026) (US$ Million)
Figure 101. Global Insulin Needle-free Syringes Consumption Market Share Forecast by Region (2021-2026)
Figure 102. Insulin Needle-free Syringes Value Chain
Figure 103. Channels of Distribution
Figure 104. Distributors Profiles
Figure 105. Porter's Five Forces Analysis
Figure 106. Bottom-up and Top-down Approaches for This Report
Figure 107. Data Triangulation
Figure 108. Key Executives Interviewed
